1. Market Research
  2. > Healthcare Market Trends
  3. > Patient-Centric Mobile Apps: Key Opportunities and Challenges for Pharma

Patient-Centric Mobile Apps: Key Opportunities and Challenges for Pharma

  • July 2015
  • -
  • Firstword Pharma

Summary

Table of Contents




Dozens of new health apps for smartphones and tablets are produced monthly. Hundreds of thousands already exist. What does it take for a patient app to stand out in this crowded space? What are the essential ingredients that differentiate an app for patients…and for pharma?


A well-designed app has the potential to increase the quality and efficiency of healthcare, to empower patients to manage their health better, and to deliver an experience patients will remember. Getting apps right is critical if Pharma is to successfully transform itself into a truly patient-centered business.


Patient-centric Mobile Apps: Key Opportunities and Challenges for Pharma gives you the information you need to understand what patients, healthcare providers and other stakeholders want in a healthcare app — and how a successful one promotes health outcomes and positive customer experiences.







Answers to Key Questions

How can pharma leverage apps to improve relationships with patients?

What does it take for healthcare providers to become advocates of your app?

What are the essential elements of a successful patient-centric healthcare app?

What types of apps are most widely recommended to patients by healthcare providers, and how do these apps augment patient care?



Key Issues Explored

Capturing and leveraging the real-world data that apps generate

Building and managing the 24/7 relationship with customers and patients through apps

Critical success factors for patient apps

How to measure and demonstrate ROI of patient apps

The future of patient apps and pharma’s evolving role


Top Takeaways

Your next partner could be a tech giant
Customer experience is now part of your job description, and you need to ace it
Healthcare apps are effectively medical devices and could be at risk for increased regulatory scrutiny
Longevity of the patient relationship will drive future app development
Learn what the customer needs before designing an app
Pharma must keep challenging itself to align communications and engagement strategies with the multichannel options available



Expert Contributors

Helena Binder, Communications Director, European Patient Panel
Michael Bodenstab, Vice President, Healthcare Solutions, Physicians Interactive
Neil Chandler, Vice President Commercial Excellence, Daiichi Sankyo
Jeremy Dalnes, Worldwide Director, Digital Strategy and Platforms, J&J
Flourent Edouard, Vice President, Commercial Excellence, AstraZeneca
Leigh Hope, Senior Product Manager, Novo Nordisk
Richard Evans, Founding Director, NexGen Healthcare
Rod Fernandez-Baca, Business Unit Director, Gilead
David Gillen, Head Patient Safety, Celgene
Helen Harrison, Digital Director, EMEA, Lilly
Dr Roger Henderson, General Practitioner, UK
Wills Hughes-Wilson, Chief Patient Access Officer, Sobi
Matt Jamieson-Evans, HealthUnlocked
Christine Jordens, Business Support Team Leader, Boehringer Ingelheim
Bernard Levy, Operations Director, Oncology, Roche
Christian Lindknud, Business Manager, Fujirebio
Dr Graeme Moyle, Director of Clinical Trials, Chelsea & Westminster Hospital
Dr Ali Parsa, CEO, Babylon Health
Rebecca Reeve, Head of KOL Relationships, UK & Ireland, Sanofi
Benjamin Tilly, Multichannel Marketing Lead, UK & Ireland, GSK





About FirstWord Reports

FirstWord is an innovative industry intelligence leader serving over 240,000 Pharma and MedTech professionals worldwide. FirstWord offers a range of products and services designed to help your company gain a competitive edge by making key business decisions with speed and confidence



FirstWord Pharma PLUS is a personalised and comprehensive intelligence service delivering up-to-the-minute pharma news, insight, analysis and expert views of importance to your company’s success.
FirstWord Reports deliver timely, need-to-know intelligence about your products, your competitors and your markets. Covering biosimilars, market access, medical affairs, sales & marketing, technology and therapy areas, FirstWord Reports provide expert views and intelligence on the challenges facing pharma today.


Get Industry Insights. Simply.

  • Latest reports & slideshows with insights from top research analysts
  • 60 Million searchable statistics with tables, figures & datasets
  • More than 25,000 trusted sources
Get This Report
24/7 Customer Support

Talk to Veronica

+1 718 514 2762

Purchase Reports From Reputable Market Research Publishers
2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

2017 World Infectious Disease Testing Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Sales and Volume Forecasts for 100 Microbiology Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies, Opportunities

  • $ 59500
  • Industry report
  • January 2017
  • by Venture Planning Group

This unique 68-country survey from VPGMarketResearch.com provides data and analysis not available from any other published source. The survey is designed to assist diagnostics industry executives, as well ...

2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

2017 World Automated Microbiology Market: North America, Europe, Asia-Pacific, LATAM, Africa, Middle East--Volume and Sales Forecasts for 100 Molecular Diagnostic Tests, Supplier Shares, Competitive Strategies, Instrumentation, Technologies

  • $ 52500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new 75-country survey from VPGMarketResearch.com provides granular data and analysis not available from any other published source. The survey is designed to help current suppliers and potential market ...

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

2017 Europe Diagnostics Market Forecasts: Blood Banking, Cancer Diagnostics, Clinical Chemistry, Coagulation, Drugs of Abuse, Endocrine Function, Flow Cytometry, Hematology, Immunoproteins, Infectious Diseases, Molecular Diagnostics, TDM

  • $ 47500
  • Industry report
  • January 2017
  • by Venture Planning Group

This new report from VPGMarketResearch.com provides granular analysis of the Europe diagnostic testing market, including Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, Finland, ...


ref:plp2015

Reportlinker.com © Copyright 2017. All rights reserved.

ReportLinker simplifies how Analysts and Decision Makers get industry data for their business.